Results 161 to 170 of about 222,974 (348)

Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions [PDF]

Hamid Alhaj, Jana Samara, Alyamama Alnamous, Rama Karima, Maha Saber-Ayad   +4 more
openalex   +1 more source

Therapeutic Drug Safety, Important to ‘Close the Gap’ for Aboriginal and Torres Strait Islanders: A Case of Phenytoin Hypersensitivity Syndrome [PDF]

, 2018

openalex   +1 more source

Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions. [PDF]

Front Genet, 2023
Manson LEN, Delwig SJ, Drabbels JJM, Touw DJ, De Vries APJ, Roelen DL, Guchelaar HJ.   +6 more
europepmc   +1 more source

Making Two out of One: Kinesin Motors Driving Plant Cell Division

Cytoskeleton, EarlyView.
ABSTRACT The Kinesin superfamily of microtubule dependent motors is present in all eukaryotes. Not all of the subfamilies are represented in all kingdoms, and the ones that are do not always show conserved functions. Tight control of the cytoskeleton is essential for proper progression and completion of mitosis and cytokinesis, and key functions are ...
Choy Kriechbaum, Sabine Müller
wiley   +1 more source

Multiple Follicular Pustules as an Atypical Cutaneous Manifestation of Drug-induced Hypersensitivity Syndrome

, 2011
Yuri Ueharaguchi, Kenji Kabashima, Chihiro Shimizuhira, W Nakajo, T. Kondo, Takashi Kamiya, K Matsubara, Sosuke Kondo   +7 more
openalex   +2 more sources

CNS tuberculoma in an immunocompetent patient: A case report of multi-drug hypersensitivity to RIPE therapy. [PDF]

IDCases, 2023
Huber B, Joshi S.
europepmc   +1 more source

Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Asciminib is the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP) in patients with chronic myeloid leukemia. This phase 1, two‐treatment‐period, drug‐drug interaction study evaluated the effect of steady‐state asciminib on the pharmacokinetics of atorvastatin.
Matthias Hoch, Wendy Weis, Felix Huth, Seshulatha Jamalapuram, Michelle Quinlan, Amarnath Bandaru, Suleyman Eralp Bellibas, Asmae Mirkou, Shruti Kapoor, Shefali Kakar   +9 more
wiley   +1 more source

Nonimmediate Hypersensitivity Reaction to Rifaximin Confirmed With a Drug Challenge Test [PDF]

, 2021
B Moya, I García-Moguel, R Mielgo, L Herráez, J. E. Crespo   +4 more
openalex   +1 more source

A Perspective on the Challenges and Issues in Developing Biomarkers for Human Allergic Risk Assessments [PDF]

, 2017
Godar, Dianne E., Merrill, Stephen, Mu, Ying   +2 more
core   +2 more sources

A Phase 1, Randomized, Open‐Label, Parallel Group Study to Evaluate the Relative Bioavailability and Safety of Subcutaneous Bepirovirsen when Delivered from a Vial or Prefilled Syringe Fitted with a Safety Syringe Device in Healthy Adult Participants

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Bepirovirsen, an antisense oligonucleotide in development for the treatment of chronic hepatitis B virus (HBV) infection, is administered from glass vials as a subcutaneous (SC) injection by healthcare professionals (HCPs). A ready‐to‐use prefilled syringe (PFS) assembled with a safety syringe device (SSD) has been developed to make ...
Amir S. Youssef, Poonam Shah, Maxwell Hu, Helene Plein, Abhishek Roy, Ravi Sharma, Sarah Mole, Magdalena Blazejczyk, Wendy Cross, Brian Spears, Samuel Pak, Rejbinder Kaur, Robert Elston, Dickens Theodore, Marjan Hezareh, Ahmed Nader   +15 more
wiley   +1 more source